Latest filing published 02 Apr 2026 for Organon & Co..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Aaron Falcione in Organon & Co., where the filings describe the role as senior executive. Between 28 February 2022 and 31 March 2026, the trades on record add up to 47 filings.
No open-market sale appears; the market trades are 1 purchase worth €43k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 28 share grants and 18 option exercises.
The record was last updated on 2 April 2026 with a share grant (€19k) in Organon & Co. The last insider purchase was made public on 7 May 2025, 535 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations